HPV vaccine programmes: Current scenario and recommendations in India.

ABSTRACT

Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M. (Centre de Recherche du CHU de Québec, Québec, Canada; Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada; Department of Infectious Disease Epidemiology, Imperial College London, London, UK; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia; Unit of Virus, Lifestyle and Genes, The Danish Cancer Society Research Centre, Copenhagen, Denmark; STD Control Branch of the California Department of Public Health, Richmond, California, USA; Virus Reference Department, Public Health England, London, UK; National HPV Vaccination Program Register, Victorian Cytology Service, East Melbourne, Melbourne, Victoria, Australia; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA; Melbourne Sexual Health Centre, Melbourne, Victoria, Australia; Central Clinical School, Monash University, Alfred Hospital, Melbourne, Victoria, Australia; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention